Literature DB >> 10611371

A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo.

A MacKenzie1, J Quinn.   

Abstract

Polymorphic regions consisting of a variable number of tandem repeats within intron 2 of the gene coding for the serotonin transporter protein 5-HTT have been associated with susceptibility to affective disorders. We have cloned two of these intronic polymorphisms, Stin2.10 and Stin2.12, into an expression vector containing a heterologous minimal promoter and the bacterial LacZ reporter gene. These constructs were then used to produce transgenic mice. In embryonic day 10.5 embryos, both Stin2.10 and Stin2.12 produced consistent beta-galactosidase expression in the embryonic midbrain, hindbrain, and spinal cord floor plate. However, we observed that the levels of beta-galactosidase expression produced by both the Stin2.10 and Stin2.12 within the rostral hindbrain differed significantly at embryonic day 10.5. Our data suggest that these polymorphic variable number of tandem repeats regions act as transcriptional regulators and have allele-dependent differential enhancer-like properties within an area of the hindbrain where the 5-HTT gene is known to be transcribed at this stage of development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611371      PMCID: PMC24806          DOI: 10.1073/pnas.96.26.15251

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Detection of serotonin receptor transcripts in the developing nervous system.

Authors:  R P Hellendall; U Schambra; J Liu; G R Breese; D E Millhorn; J M Lauder
Journal:  J Chem Neuroanat       Date:  1992 Jul-Aug       Impact factor: 3.052

Review 2.  Boundary functions in the control of gene expression.

Authors:  J C Eissenberg; S C Elgin
Journal:  Trends Genet       Date:  1991-10       Impact factor: 11.639

Review 3.  Association between the serotonin transporter gene and affective disorder: the evidence so far.

Authors:  A D Ogilvie; A J Harmar
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

4.  Effect of serotonin on the development of a rat cerebral cortex tissue culture.

Authors:  A R Chubakov; E A Gromova; G V Konovalov; E I Chumasov; E F Sarkisova
Journal:  Neurosci Behav Physiol       Date:  1986 Nov-Dec

Review 5.  Serotonergic neuronal systems: what their anatomic organization tells us about function.

Authors:  M E Molliver
Journal:  J Clin Psychopharmacol       Date:  1987-12       Impact factor: 3.153

6.  Prenatal expression of 5-HT1C and 5-HT2 receptors in the rat central nervous system.

Authors:  R P Hellendall; U B Schambra; J P Liu; J M Lauder
Journal:  Exp Neurol       Date:  1993-04       Impact factor: 5.330

7.  Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain.

Authors:  A R Aitken; I Törk
Journal:  J Comp Neurol       Date:  1988-08-01       Impact factor: 3.215

8.  VNTR polymorphism for the human dopamine transporter gene (DAT1).

Authors:  W Byerley; M Hoff; J Holik; M G Caron; B Giros
Journal:  Hum Mol Genet       Date:  1993-03       Impact factor: 6.150

9.  Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons.

Authors:  P G Haydon; D P McCobb; S B Kater
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

10.  Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons.

Authors:  P M Whitaker-Azmitia; E C Azmitia
Journal:  Brain Res       Date:  1989-09-11       Impact factor: 3.252

View more
  82 in total

1.  Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.

Authors:  Q Li; C Wichems; A Heils; K P Lesch; D L Murphy
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 2.  Role of pharmacogenomics in individualising treatment with SSRIs.

Authors:  Dalu Mancama; Robert W Kerwin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 3.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 4.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

5.  Social supports and serotonin transporter gene moderate depression in maltreated children.

Authors:  Joan Kaufman; Bao-Zhu Yang; Heather Douglas-Palumberi; Shadi Houshyar; Deborah Lipschitz; John H Krystal; Joel Gelernter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

6.  Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder.

Authors:  R Delorme; C Betancur; M Wagner; M O Krebs; P Gorwood; P Pearl; G Nygren; C M Durand; F Buhtz; P Pickering; J Melke; S Ruhrmann; H Anckarsäter; N Chabane; A Kipman; C Reck; B Millet; I Roy; M C Mouren-Simeoni; W Maier; M Råstam; C Gillberg; M Leboyer; T Bourgeron
Journal:  Mol Psychiatry       Date:  2005-12       Impact factor: 15.992

7.  The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients.

Authors:  Yuyuan Li; Yuqiang Nie; Jun Xie; Weizhan Tang; Peizhi Liang; Weihong Sha; Hui Yang; Yonyjian Zhou
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

8.  Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder.

Authors:  C Betancur; M Corbex; C Spielewoy; A Philippe; J L Laplanche; J M Launay; C Gillberg; M C Mouren-Siméoni; M Hamon; B Giros; M Nosten-Bertrand; M Leboyer
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

9.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

10.  Interspecies and intraspecies variations in the serotonin transporter gene intron 3 VNTR in nonhuman primates.

Authors:  Miho Inoue-Murayama; Emi Hibino; Hiromi Iwatsuki; Eiji Inoue; Kyung-Won Hong; Toshisada Nishida; Ikuo Hayasaka; Shin'ichi Ito; Yuichi Murayama
Journal:  Primates       Date:  2008-01-18       Impact factor: 2.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.